How is Dihexa administered?
This describes how Dihexa is typically administered in clinical and research references, not a self-administration guide. The usual route is Oral or transdermal (not injected), on a daily schedule, generally over 2-4 weeks at a time. Specific dosing is individual and beyond general information, and human evidence for Dihexa is limited.
Administration at a glance (reference data)
- Route: Oral or transdermal (not injected)
- Schedule: Daily
- Cycle length: 2-4 weeks at a time
- Half-life: ~hours (poorly characterized in humans)
References
- The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases — Wright JW, Kawas LH, Harding JW. Progress in Neurobiology, 2015
- A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases — Wright JW, Harding JW. Frontiers in Endocrinology, 2013
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Dihexa
Last updated 2026-06-15.